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Masayuki Tsukamoto1,3, Hideki Watanabe2, Ayako Ooishi2 and Shinya Honda1,2,3*Abstract
Background: In antibody purification processes, the acidic buffer commonly used to elute the bound antibodies
during conventional affinity chromatograph, can damage the antibody. Herein we describe the development of
several types of affinity ligands which enable the purification of antibodies under much milder conditions.
Results: Staphylococcal protein A variants were engineered by using both structure-based design and combinatorial
screening methods. The frequency of amino acid residue substitutions was statistically analyzed using the sequences
isolated from a histidine-scanning library screening. The positions where the frequency of occurrence of a histidine
residue was more than 70% were thought to be effective histidine-mutation sites. Consequently, we identified PAB
variants with a D36H mutation whose binding of IgG was highly sensitive to pH change.
Conclusion: The affinity column elution chromatograms demonstrated that antibodies could be eluted at a higher pH
(ΔpH**≧2.0) than ever reported (ΔpH = 1.4) when the Staphylococcal protein A variants developed in this study were
used as affinity ligands. The interactions between Staphylococcal protein A and IgG-Fab were shown to be important
for the behavior of IgG bound on a SpA affinity column, and alterations in the affinity of the ligands for IgG-Fab clearly
affected the conditions for eluting the bound IgG. Thus, a histidine-scanning library combined with a structure-based
design was shown to be effective in engineering novel pH-sensitive proteins.
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Monoclonal antibodies are currently one of the most
important applications in biotechnology and as a prom-
ising class of drugs in the biopharmaceutical industry
[1,2]. Affinity chromatography is commonly used for anti-
body purification on both the laboratory and industrial
scale because it provides easy, fast and selective purification
[3]. However, conditions for efficiently eluting monoclonal
antibodies from affinity columns require improvement.
Conventional affinity chromatography for antibodies uses
an acidic buffer solution for elution, which would cause
antibodies to denature and/or to form aggregates, leading
to immunogenicity and other adverse reactions [4,5]. To* Correspondence: s.honda@aist.go.jp
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article, unless otherwise stated.solve these problems, several types of affinity ligands have
been developed for the elution of antibodies under milder
conditions [6-11].
The affinity ligands commonly used for antibody puri-
fication are Staphylococcal protein A (SpA) and Strepto-
coccal protein G (SpG). Optimizing the pH-sensitive
interactions of these affinity ligands with the target anti-
bodies could improve elution conditions and guarantee
the quality of purified antibody. A number of studies using
various strategies [7,9-19] to modulate the pH sensitivity
of protein-protein interactions have been carried out.
Most of pH-sensitive* proteins in these studies were
produced by introducing histidine-mutations based on
structural designs, such as that by Brown et al. [7] on
engineered pH-sensitive SpA B-domain (PAB) variants.
In previous studies, we developed rational strategies for
histidine-mutations to produce pH-sensitive IgG-binding
SpG [9] and SpA [11].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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plore the most effective positions for histidine-substitution.
Gera et al. [10] performed a histidine-scanning mutagenesis
study where a number of Sso7d protein variants with indi-
vidual single histidine-substitutions were systematically ex-
amined; they identified a pH-sensitive mutant containing a
single histidine substitution. In addition to these structure-
based designs, combinatorial screening is also a promising
approach. Murtaugh et al. [19] reported the engineering of
pH-sensitive proteins using a histidine-scanning library of
anti-RNase A single domain VHH antibodies, and identi-
fied pH-sensitive antibodies with multiple histidine substi-
tutions that retained near wild-type affinity but with high
sensitivity to pH change for elution.
In this paper, we describe the design and generation of
pH-sensitive PAB variants by introducing a histidine-
mutation using both structure-based design and combina-
torial screening. First, a histidine-scanning library for PAB
was created based on structural information. The effective
histidine-mutation positions were evaluated from statis-
tical analysis of the frequency of occurrence of amino
acids in the sequences isolated using a T7 phage display
screening. We also investigated the pH value at which IgG
peaks eluted from PAB variant-immobilized affinity col-
umns. To better understand the effects of histidine-
mutation at molecular level, we evaluated the structural
stability of each histidine-substituted PAB variant and
its binding affinity to IgG by Surface Plasmon Reson-
ance (SPR) analysis.Results and discussion
Generation of histidine-scanning library
To design the histidine-scanning library, we focused on
the IgG-Fc binding interface of PAB for the mutation posi-
tions to be randomized. Our previous study [9] revealed
that positions near positively charged residues on a targetTable 1 Mutation positions for histidine-scanning library
Number 5 6 9 10 11 13 14
Aminoacid residue
of wild type
F N Q Q N F Y
Distance (Å) 5.7 11 6.4 4.2 6.5 3.8 3.4
fSASA (%) 78 94 36 47 64 40 63
Mixed codon used in
the library
YWT MAY CAW CAW MAY YWT YAT
Substituted amino acids in
the library
H H
Y H H H H Y H
L L
Distance in the table indicates the length between the PAB residue and the neares
exposure of the side chain in wild-type amino acid residues of PAB. The seventeen
residues were located within 9 Å from the positively charged IgG-Fc residues and (2
and with a fractional solvent-accessible surface area (fSASA) ((fSASA) = (SASA) (nativ
are used for mixed bases: R = (A or G), Y = (C or T), M = (A or C), K = (G or T), S = (G o
non-wild-type residues encoded by a mixed codon.protein were effective sites for histidine-mutation. First,
positively charged residues (histidine, lysine and arginine)
on IgG1-Fc under acidic conditions were searched using
the structure of PAB complexed with IgG1-Fc [pdb: 1FC2]
[20]. Distances from the positively charged residues in
IgG1-Fc to all the PAB residues were calculated (Table 1).
Next, the solvent exposure of each residue in PAB was
calculated in order to select the residues on the protein
surface using the subunit structure of PAB in the com-
plex (Table 1).
Several residues important in the interaction between
PAB and IgG1-Fc have been previously identified by mu-
tational experiments [7,11,21-24] and by molecular simu-
lation calculations [25,26]. However, we did not take these
positions into particular consideration for our library
design in order to test a wide range of mutation posi-
tions in PAB.
The theoretical molecular diversity of a histidine-
scanning library can be controlled by the number of
mutation positions. In order to restrict the library to fit
within the size range of T7 phage-display screening, we
determined the maximum number of mutation posi-
tions. The seventeen mutation positions were finally se-
lected (Table 1).Screening of histidine-scanning library
The histidine-scanning library was screened using a T7
phage-display method. The initial library size (5.4 × 107
pfu) of T7 phages estimated by plaque assays was larger
than the theoretical value (2.5 × 107 pfu) of the objective
library, so a highly diverse library was produced.
After each round of selection, the T7 phages were cloned
and several dozen of the sequences were determined. The
ratios of unique sequences out of the sequences determined
after each round were as follows (the number of unique se-
quences/the number of total sequences determined): 100%15 17 24 25 27 28 31 32 35 36
E L E E R N I Q K D
7.9 4.0 8.4 8.7 8.6 6.9 5.8 8.1 4.5 9.8
50 46 78 96 23 71 17 60 64 68
SAW CWK SAW SAW CRY MAY MWT CAW MAW SAT
H H H H H H
D Q D D H H N H N H
Q Q Q L Q
t positively charged residue in IgG-Fc. fSASA indicates the extent of solvent
mutation positions finally selected were classified into two groups: (1) the PAB
) the PAB residues were located between 9 and 11 Å from the IgG-Fc residues,
e)/SASA (denatured)) value of more than 68%. The following abbreviations
r C) and W = (A or T). Substituted amino acid residues in the library indicate
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97.5% (after the 2nd round: 78/84), 51.7% (after the 3rd
round: 30/58), 25.0% (after the 4th round: 20/88), and
19.3% (after the 5th round: 18/93). Sixty one out of 93
clones examined after the final round had identical se-
quences (Additional file 1: Table S2). It should be men-
tioned that the frequency of occurrence of the wild-type
or histidine residue at each mutation position fluctuated
(Additional file 2: Figure S1, Additional file 3: Figure S2
and Additional file 4: Figure S3).
Frequency of occurrence of amino acid residues of
isolated PAB variants
The frequency of occurrenc of the amino acids was calcu-
lated from 18 unique sequences determined from the final
round (Figure 1). The positions at which the frequency of
the histidine residue was less than 20% were: F13, Y14,
L17, E24 and I31, which were previously shown to be es-
sential for the interaction with IgG-Fc [6,7,21-26]. For
example, Brown et al. [7] used ELISA to show that the
binding affinity of rabbit IgG with a PAB mutant (F13H)
at pH 8.0 was more than 100-fold weaker than with wild-
type PAB.
The positions at which the frequency of occurrence of
a histidine residue was more than 70% were expected to
be effective histidine-mutation sites. They were: Q9,
Q10, R27, K35 and D36. The frequency of a histidine
residue at D36 was the highest, although D36 has been
little investigated in previous studies [7,21-26]. Hence, a
single histidine-substituted (D36H) PAB variant and
four double histidine-substituted PAB ones containing
the D36H mutation and either the Q9H, Q10H, R27H
or K35H mutation were produced.5 6 9 10 11 13 14 15
WT 16.7 72.2 27.8 27.8 50.0 33.3 88.9 16.7
His 55.6 27.8 72.2 72.2 50.0 11.1 11.1 38.9






















Figure 1 Frequency of occurrence of amino acid residues after the fin
calculated from 18 unique determined sequences of PAB variants after the
of occurrence. The abscissa indicates the amino acid residue number. WT,
non–histidine residues. The number in the lower three rows indicate perceElution profile of bound IgG from the PAB variant
columns
The affinity chromatograms with the PAB variants de-
scribed above indicated that the pH values at which IgG
eluted from all the PAB variant columns were higher than
the elution pH from the PAB01 (Wild-type (WT)) column
(Table 2, Additional file 5: Figure S4). First, the pH sensi-
tivity of PAB02 (D36H) was clearly higher. For the double
substitution PAB variants, the pH values of the IgG elu-
tion peaks from the PAB03 (Q9H, D36H) and PAB04
(Q10H, D36H) columns were significantly higher than
that of the PAB02 (D36H) column. On the other hand,
the pH required to elute IgG from the PAB05 (R27H,
D36H) and PAB06 (K35H, D36H) column was similar to
that of the PAB02 column. Therefore, the Q9, Q10 and
D36 histidine-mutations showed much better pH sensitiv-
ity. The ΔpH of the IgG elution peaks from the PAB03
and PAB04 columns was more than ever reported (Table 2,
Additional file 6: Table S3).
Next, we evaluated the effects of combinations of the
histidine-mutations. The pH values for eluting IgG from
a single histidine-substituted PAB variant (PAB07 (Q9H)
or PAB08 (Q10H)) column was slightly higher than that
required with PAB01. Thus, the large effects of Q9H
and Q10H on the pH sensitivity of the PAB03 and
PAB04 columns were likely due to the combination ef-
fect with D36H.
Structural stability of PAB variants
We attempted to evaluate the effect of introducing a
histidine-mutation on the structure and thermal stability
of PAB variants. The circular dichroism (CD) spectra of
all PAB variants at room temperature were similar to17 24 25 27 28 31 32 35 36
83.3 55.6 22.2 27.8 44.4 38.9 61.1 16.7 11.1
5.6 16.7 22.2 72.2 55.6 11.1 38.9 83.3 88.9
11.1 27.8 55.6 50.0 0.0
sidue number
al round. The frequency of occurrence of amino acid residues was
final round. The ordinate indicates the percentage of the frequency
wild-type residue: His, histidine residue: Others, non-wild-type and
ntage.
Table 2 The pH values of the IgG elution peaks and the
thermal stability of PAB variants
Protein Elution Peak ΔpH Stability ΔTm
pH Tm (K)
PAB01 (Wild Type) 3.5 - 346.4 -
PAB02 (D36H) 4.6 1.1 345.8 −0.6
PAB03 (Q09H, D36H) 5.5 2.0 343.7 −2.7
PAB04 (Q10H, D36H) 6.8 3.3 343.1 −3.3
PAB05 (R27H, D36H) 4.7 1.2 316.2 −30.2
PAB06 (K35H, D36H) 4.4 0.9 342.5 −3.9
PAB07 (Q09H) 3.9 0.4 344.9 −1.5
PAB08 (Q10H) 3.7 0.2 343.6 −2.8
PAB10 (Q32H) 4.2 0.7 341.4 −5.0
Affinity columns were prepared using the PAB variants. The captured IgG on
each column was eluted with a decreasing pH gradient. The pH value in the
table indicates the peak position of the eluted IgG on the affinity
chromatography. The midpoint of the transition during thermal denaturation
(Tm) was determined from circular dichroism melting measurements.
ΔpH = (the pH value at which IgG eluted from mutant column) - (the pH value
at which IgG eluted from wild-type column).
ΔTm = (the thermal stability of PAB mutant expressed as Tm) - (that of the
thermal stability of PAB wild-type, PAB01).
Table 3 Binding affinity of IgG for PAB variants








PAB01 (WT) 5.1 ± 3.2 - 7.6 ± 4.3 -
PAB02 (D36H) 33.6 ± 19.2 6.6 832 ± 443 110
PAB03 (Q9H, D36H) 288 ± 146 56 ND -
PAB04 (Q10H, D36H) 6830 ± 3600 1300 ND -
PAB05 (R27H, D36H) 80.7 16 2090 270
PAB06 (K35H, D36H) 550 ± 143 110 3860 510
PAB07 (Q9H) 13.9 ± 6.3 2.7 30.6 4
PAB08 (Q10H) 50.8 ± 20.5 10 951 120
PAB09 (R27H) 5.6 ± 1.3 1.1 7.0 0.92
PAB10 (Q32H) 2.8 ± 1.3 0.55 96.8 13
The binding assay was performed under neutral (pH = 7.4) and acidic
(pH = 5.0) conditions using SPR. The IgG was immobilized on the surface of a
CM5 sensor chip (GE Healthcare).
KD, equilibrium dissociation constant: KD ratio, (KD of histidine-substituted PAB
variant)/(KD of Wild-type PAB): ND, not determined.
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during thermal denaturation (Tm) was determined from
CD melting measurements (Table 2, Additional file 7:
Figure S5). The pH-sensitive PAB variants with effective
histidine-mutations (Q9H, Q10H and D36H) showed a
slight decrease in thermal stability. An increase in the
number of histidine-mutations led to a decrease in the Tm
value. Thus, histidine-mutations apparently have additive
effects on thermal stability. In summary, however, the de-
crease in thermal stability due to histidine-mutations was
rather limited and would not prevent utilization of these
mutants as affinity ligands.Binding assay of PAB variants
Interaction under neutral conditions
We examined the binding affinity of IgG for each of the
four single histidine-substituted PAB variants under
neutral conditions (pH = 7.4) (Table 3). Of these, PAB08
(Q10H) showed the weakest binding affinity, about
10-fold weaker than that of PAB01 (WT). The binding
affinities of IgG for the double histidine-substituted PAB
variants containing D36H were lower than those of their
single substitution PAB variant counterparts. PAB03
(Q9H, D36H) was exhibited 56-fold weaker binding
affinity than PAB01. Thus, the IgG binding of PAB
variant columns in this study was decreased (Additional
file 8: Figure S6). Still, except for PAB04, the interaction
between IgG and each of the PAB variants with single or
double histidine substitutions would be strong enough
to retain IgG on an affinity column using these variants
as ligands.Interaction under acidic conditions
The binding affinity of IgG for PAB01 under the acidic
condition (pH = 5.0) (Table 3) was about 1.5-fold weaker
than at neutral pH, still quite strong. PAB07 (Q9H) and
PAB09 (R27H) also retained strong affinity. Brown et al.
[7] showed that the K35H PAB variant exhibited strong
affinity under both neutral (pH = 8.0) and acidic (pH = 5.0)
conditions.
On the other hand, the binding affinity of IgG for PAB02
(D36H) and PAB08 (Q10H) was more than 100-fold
weaker than that for PAB01. The binding affinities for
PAB03 (Q9H, D36H) and PAB04 (Q10H, D36H) were too
weak to be determined under the acidic condition. Thus,
histidine-mutations at Q9, Q10 and D36, as well as the
double-mutations, Q9H plus D36H and Q10H plus D36H,
appeared to have favorable pH-sensitivity. It should also be
noted that histidine-mutation at D36 improved the pH
sensitivity of all the four histidine-mutations under both
neutral and acidic conditions.
The effects of histidine-mutations
The observed effects of the histidine-mutations could be
explained based on crystal structure and biophysical data.
Q9 and Q10 of PAB probably contribute to the interaction
with IgG-Fc. The binding affinity of PAB08 (Q10H) under
the neutral condition was about 10-fold weaker than that of
PAB01 (WT). Five residues in IgG-Fc are found within 4 Å
of Q10 of PAB. Therefore, the steric hindrance generated by
the Q10H mutation likely affects the interaction with
IgG-Fc. IgG elution from the affinity columns and SPR
measurement results under the acidic condition demon-
strated that the effects of histidine-mutation at Q10 are
more significant than mutation at Q9. Because the positively
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PAB (<4.2 Å), electrostatic repulsion would increase when
the pH value changes from neutral to acidic.
As described below, however, the decrease in binding
affinity due to the D36H mutation (PAB02) was unlikely
to be affected by modulation of the interaction of the
IgG-Fc binding interface of PAB.
Effect of the D36H mutation
Ile253 of IgG-Fc resides 6.89 Å from D36 of PAB in the
PAB-IgG1-Fc complex [20]. Since this is not a short dis-
tance, the effects of the histidine-mutation at D36 ob-
tained from the screening experiment are difficult to
explain if the effect were caused by modulation of the
interaction between PAB and IgG-Fc. In fact, it was previ-
ously observed that SpA binds not only to IgG-Fc but also
to IgG-Fab [27-30]. We focused on the IgG-Fab binding
interface of PAB.
We evaluated the binding affinity of IgG-Fc and IgG-
Fab for PAB01 (WT) and PAB02 (D36H) (Tables 3 and 4)
using SPR. The interaction between PAB02 and IgG-Fc
was found to be similar to that of PAB01 under both neu-
tral and acidic conditions. On the other hand, the binding
affinity of PAB02 for IgG-Fab under the neutral condition
was 2.3-fold weaker than that of PAB01, and the binding
affinity of PAB02 under the acidic condition was too weak
to be determined. These results suggested that the inter-
action of IgG-Fab with PAB would significantly contribute
to the effects of histidine-mutation at D36.
Next, we analyzed the effects of D36H using the struc-
ture of SpA D-domain complexed with IgG-Fab [30]. D36
is conserved in all the SpA domains (A, B, C, D and E).
The crystal structure indicates that six residues in IgG-Fab
are within 4 Å of D36 in PAB. Therefore, the steric hin-
drance due to the histidine-mutation of D36 would affect
the interaction with IgG-Fab under neutral conditions.Table 4 Binding affinity of IgG-Fc (upper rows) or IgG-Fab
(lower rows) for PAB01 (WT) and PAB02 (D36H)








PAB01 (WT) 12.8 - 1080 -
PAB02 (D36H) 15.5 1.2 1350 1.3








PAB01 (WT) 2.9 - ND -
PAB02 (D36H) 6.7 2.3 ND -
The binding assay was performed under neutral (pH = 7.4) and acidic (pH = 5.0)
conditions using SPR. IgG-Fc or IgG-Fab was immobilized on the surface of a
CM5 sensor chip (GE Healthcare).
KD, equilibrium dissociation constant: KD ratio, (KD of histidine-substituted PAB
variant)/(KD of Wild-type PAB or PAZ): ND, not determined.Because a positively charged residue (Arg2519) in IgG-Fab
is present near D36 in PAB (<3.0 Å), electrostatic repul-
sion under acidic conditions should be stronger than
under neutral conditions.
We also focused on Arg2519 in IgG-Fab as it would
be involved in the effects of histidine-mutation of D36.
Q32 of PAB is located within 4 Å of Arg2519 of IgG-
Fab. The PAB Q32H variant (PAB10) was produced, and
the pH value of the IgG elution peaks from the affinity
column with PAB10 was found to be significantly higher
than those values for PAB01 (WT), PAB07 (Q9H) and
PAB08 (Q10H) columns. This suggested that the intro-
duction of histidine-mutations into the IgG-Fab binding
interface of PAB was as effective as introducing them
into the IgG-Fc binding interface. In addition, the major-
ity of amino acid residues corresponding to Arg2519 of
the top 10 therapeutic antibodies are positively charged
ones (Additional file 9: Table S4). Therefore, the PAB
affinity ligands with D36H mutation should be effective
for therapeutic antibody purification.
Although the binding affinity of IgG-Fab for PAB01
(WT) was more than 1000-fold weaker than that of IgG-
Fc (Table 4), a possible reason for the remarkable effects
of the D36H mutation would be a change in avidity. IgG
has four SpA binding sites: two are strong binding sites
in the IgG-Fc region and two are weak binding sites in
the IgG-Fab region. On an affinity column, since a plur-
ality of interactions for these four sites would bind the
IgG molecule, the cooperative effect of interactions be-
tween SpA and IgG would be strong. Since the D36H
mutation would result in just 2 binding sites instead of 4
in the interaction with IgG, the effect of avidity would
likely decrease significantly, thus promoting dissociation
under moderately acidic conditions.
Elution profile of bound IgG from 4 × PAZ variant columns
An affinity column of tandem SpA (4 × PAZ) consisting of
four SpA Z-domains was fabricated using pH-sensitive
double substituted PAB variant (PAB03) and its perform-
ance was compared with commercially available affinity
columns (Figure 2).
IgG was eluted with a stepwise pH decrease. The rela-
tive amounts of IgG eluted under mild acidic conditions
(pH= 5 ~ 6) was 67% at pH = 6.0, 82% at pH = 5.5 and 90%
at pH = 5.0. In contrast, IgG bound to the 4 × PAZ01 col-
umn or to a commercially available SpA column (rProtein
A) (GE Healthcare) did not elute at pH = 5.0. Although a
part of IgG injected onto the 4 × PAZ03 column seemed to
flow through, more than the case of the 4 × PAZ01 col-
umn, with pH 7.5 binding buffer, the amounts of IgG leak-
ing out were very little, if any, with pH 9.0 binding buffer
(Additional file 10: Figure S7). Thus, the 4 × PAZ03 (Q9H,
D36H) column would allow the retention of IgG by opti-






























































Figure 2 Elution profile of IgG on affinity columns with
immobilized 4 × PAZ variants. (a) Elution profile of IgG from affinity
columns prepared with immobilized 4 × PAZ03. IgG was eluted with
pH 5.0, pH 5.5 or pH 6.0 buffer, (b) Elution profile of IgG from affinity
columns prepared with immobilized 4 × PAZ01 or rProteinA
(GE Healthcare). Elution was performed using pH 5.0 buffer. Affinity
columns were prepared using the 4 × PAZ variants. The captured IgG
on the column was eluted using a buffer with the pH indicated in
the Figure. Afterwards, the residual IgG was eluted with a decreasing
pH gradient. The ordinate on the right indicates the pH of the
solution. The ordinate on the left indicates the absorbance at 280 nm
(mAU: milliabsorbance units). The abscissa indicates the elution
volume. The solid and dashed lines show the elution patterns of IgG
on 4 × PAZ variants or rProteinA (GE Healthcare) columns, as shown
in the Figure, and the pH value of the elution buffer, respectively.
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ously reported [7,8,11].
Conclusion
We have shown that a histidine-scanning library combined
with a structure-based design was effective in engineeringnovel pH-sensitive proteins. The positions at which histi-
dine residues occurred with high frequency should be suit-
able sites for introducing histidine-mutations. Large effects
of PAB mutations such as Q9H and Q10H, combined with
D36H, were observed. The chromatograms demonstrated
that antibodies could be eluted at a higher pH than ever
reported previously when the protein A variants developed
in this study were used as affinity ligands. The interactions
between SpA and IgG-Fab are apparently important for the
behavior of IgG bound on a SpA affinity column, and alter-
ations in the affinity of the ligands for IgG-Fab affected the
elution condition for bound IgG. Therefore, not only the
interactions with IgG-Fc but also with IgG-Fab should be




Distances from positively charged residues (histidine, ly-
sine and arginine residues) on IgG1-Fc to all residues of
PAB in the crystal structure of the complex of PAB
bound to IgG1-Fc [pdb: 1FC2] (Table 1) [20] were calcu-
lated using the program CONTACT in CCP4 suite [31].
The solvent-accessible surface area (SASA) was calculated
for the subunit structure of PAB in the complex. The
extent of solvent exposure of all residues of PAB was de-
termined by the equation (Table 1) fSASA (a fractional
solvent-accessible surface area) = SASA (native)/SASA
(denatured), where a Gly-Xaa-Gly tripeptide model was
assumed to adopt the denatured structure. The calcula-
tion was performed using surface Racer 3.0 [32].
Gene fragments for constructing a mutated PAB library
were prepared with chemically synthesized oligonucleo-
tides (Additional file 11: Table S1), purchased from
Rikaken, by the overlap extension method using combina-
tions of these oligonucleotides. At the mutation position
of the oligonucleotide, we introduced mixed codons
comprising three mixed nucleotides, encoding either
the wild-type residue or a histidine residue. However,
genes encoding neither the wild-type nor a histidine resi-
due at that position were also produced, since the codon
was a random mixture of three nucleotides. Consequently,
genes encoding three or four different kinds of residues
were obtained for several mutation positions.
The gene fragments thus prepared were treated with
restriction enzymes EcoR Ι and Hind ΙΙΙ and linked to
the 3′-terminal side of the g10 gene on the T7 phage
genome through ligation reaction (16°C, 16 hr) with T7
phage vector (T7Select1-1b) (Novagen). The linked T7
phage genome was subjected to an in vitro T7 phage
particle packaging reaction (22°C, 2 hr) to prepare the
initial library.
An E. coli BLT5403 strain cultured in 200 mL LB
medium to O.D.600 = 1.0 was infected with this initial
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tion. About 4 hours after infection, the amplified phages
were recovered (T7 phages have bacteriolytic ability and
are thus released from the bacterial body) in the super-
natant after centrifugation. To the supernatant, 1/6 volume
of 50% polyethylene glycol (PEG, molecular weight: 8000)
and 1/10 volume of 5 M NaCl were added, and the mixture
was stirred at 4°C overnight. The PEG-precipitated phages
were partially purified by centrifugation. Then, the phages
were lysed by repeated pipetting in TBST buffer (10 mM
Tris–HCl (pH = 7.5), 150 mM NaCl, and 0.1% Tween
20) and the resultant suspension was filtered through a
0.22 μm filter to obtain the phage library displaying the
mutated PAB. This is referred to as the initial phage
library.Phage panning and selection
Human monoclonal IgG1 antibody (Chugai) was bio-
tinylated using NHS-biotin (Roche) according to the
manufacturer’s protocol. The biotinylated monoclonal
antibody was mixed with streptavidin magnetic beads
(Promega) to immobilize the antibodies on the mag-
netic beads.
For the binding step, the suspension of the phage library
(109 ~ 1011 phage/mL titer) displaying the mutated PAB
prepared above was added to the biotinylated antibody-
immobilized magnetic beads, and the mixture was shaken
at 25°C for 1 hour. Afterwards, the beads with bound
phages were pulled down by using a magnetic stand (Pro-
mega). The beads were washed 10 to 20 times with TBST
buffer to remove antibody-unbound phages.
For the elution step, phages specifically bound with
the antibodies were recovered by adding a 50 mM so-
dium acetate solution (pH = 5.0). The eluted phages were
subjected to the infection/amplification/PEG-precipita-
tion operation described in the preceding paragraph to
prepare the phage library displaying the mutated PAB.
This is referred to as the phage library after the first
round.
The operation described above, i.e., the screening ex-
periment, was repeated 5 times in total. The eluting so-
lution used in the screening experiment from the second
round onwards was 50 mM sodium acetate (pH = 6.0).
The selective pressure of screening was changed at each
stage by gradually decreasing the amount of biotinylated
antibody-immobilized magnetic beads.Protein preparation
Expression vectors for single or double histidine-
substituted PAB variants were prepared using a Quick-
Change™ site-directed mutagenesis kit (Stratagene). The
expression vector for wild-type PAB (pET16-b) was
used as the template. The primer sequences (Rikaken)used for this procedure are shown in Additional file 11:
Table S1.
The expression vectors for the tandem SpA Z-domain
(4 × PAZ) variants comprised artificial pET16-b vectors
containing four sets of the SpA Z-domain gene and the
C-terminal cysteine codon and were purchased from
Genscript.
E. coli strain BL21 (DE3) was transformed with these
plasmid vectors and cultured in 2 × YT medium contain-
ing 100 μg/ml ampicillin to O.D.600 = 0.8 to 1.0 at 37°C.
Recombinant gene expression of PAB and the 4 × PAZ
variants was induced by the addition of isopropylthio-β-
D-galactopyranoside (IPTG) to a final concentration of
1 mM, then the transformants were further cultured at
37°C for 2 hours. The bacteria harvested were suspended
in TBST buffer and homogenized by ultrasonication.
PAB and 4 × PAZ variants were purified from the cell
lysate by IgG Sepharose 6 Fast Flow chromatography
(GE Healthcare). The purity of the sample was checked
with Tricine-SDS-PAGE.
Affinity chromatography
To prepare a PAB variant-immobilized affinity column, a
purified PAB variant was applied to a HiTrap NHS HP
column (GE Healthcare), incubated at room temperature
(overnight), and then washed with 0.5 M acetic acid
(pH 2.5). Affinity chromatography was performed with an
AKTA purifier (GE Healthcare) using the columns as
above. Human IgG1 was injected onto the column
equilibrated with TBST buffer. The captured IgG was
eluted with a decreasing pH gradient by using 50 mM
sodium citrate (pH = 7.0) and 0.5 M acetic acid (pH =
2.5) (Table 2, Additional file 5: Figure S4). The chro-
matograms obtained were processed using UNICORN
version 4.12 (GE Healthcare).
To prepare a tandem SpA Z-domain (4 × PAZ) variant-
immobilized affinity column, a purified 4 × PAZ variant
was chemically coupled to sepharose resin through the
sulfhydryl group of the C-terminal cysteine using a Sulfo-
Link Immobilization kit (Pierce). Affinity chromatography
was performed as above. The captured IgG was eluted
using 50 mM sodium citrate (pH = 5.0, 5.5 or 6.0). After-
wards, the residual IgG on the 4 × PAZ column was eluted
with a decreasing pH gradient by using 50 mM sodium
citrate (pH = 5.0, 5.5, or 6.0) and 0.5 M acetic acid (pH =
2.5) (Figure 2).
Stability analysis
PAB variants were dissolved in 50 mM sodium phosphate
(pH= 7.0). Circular dichroism (CD) spectra were obtained
on a J-805 spectropolarimeter (JASCO) at various temper-
atures. CD melting curves were obtained by monitoring
the ellipticity at 222 nm with increasing temperature from
278 to 373 K at a heating rate of 1.0 K/min. The
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unfolding were obtained through a fitting calculation using
a two-state transition model [33] on the assumption that
heat capacity changes (ΔCp) of all proteins are constant
and fixed to the value of the wild-type domain (ΔCp =
2.643 kJ/mol•K) (Table 2). The value of ΔCp was estimated
using the linear relationship between molecular weight and
ΔCp displayed by various proteins [34]. Numerical fitting
calculations were carried out using IGOR software (Wave-
metrics). Other procedures were the same as described
previously [35].
Binding affinity analysis
Binding analyses of a PAB variant to IgG, IgG-Fc and
IgG-Fab were performed using a Biacore T100 (GE
Healthcare). Either 4000 resonance units (RU) of human
monoclonal IgG1, 1250 RU of the Fab region of human
polyclonal antibody (Jackson Immunoresearch), or 1250
RU of the Fc region of human polyclonal antibody
(Jackson Immunoresearch) was immobilized on the
surface of a CM5 sensor chip (GE Healthcare) using
amine coupling chemistry. A binding assay was performed
under neutral and acidic conditions as follows: (1) 10 mM
HEPES (pH = 7.4), 150 mM NaCl and Tween 20 (0.05%);
(2) 10 mM sodium acetate (pH = 5.0), 150 mM NaCl and
Tween 20 (0.05%). The binding data was fitted to a 1:1
binding model to determine the dissociation constant
(KD) using Biacore T100 Evaluation software (Tables 3
and 4).
Endnote
*In this study, ligand proteins with favorable pH sensi-
tivities are referred to as “pH-sensitive”. **ΔpH = (the pH
value at which IgG eluted from mutant column) - (the pH
value at which IgG eluted from wild-type column).
Additional files
Additional file 1: Table S2. Eighteen unique sequences of PAB variants
after the final round. Amino acid residues at the indicated position
number are shown for PABwild-type and for 18 unique sequences from the
final round, PABT7phage01-18.
Additional file 2: Figure S1. Frequency of occurrence of amino acid
residues for each mutation position (5F, 6N, 9Q, 10Q, 11N and 13F). The
frequency of occurrence of amino acid residues was calculated from the
determined sequences of PAB variants after each round. The title of each
section of the Figure, such as Position 5F, indicates the wild-type residue
(in this case, F) of the mutation position. The ordinate indicates the
percentage of the frequency of occurrence. The abscissa indicates the
round number. Wild-type residue (blue), Histidine residue (red),
Non-wild-type and non–histidine residues (green or purple).
Additional file 3: Figure S2. Frequency of occurrence of amino acid
residues for each mutation position (14Y, 15E, 17L, 24E, 25E and 27R).
see the caption in Additional file 2: Figure S1.
Additional file 4: Figure S3. Frequency of occurrence of amino acid
residues for each mutation position (28N, 31I, Q32, 35K and 36D). see the
caption in Additional file 2: Figure S1.Additional file 5: Figure S4. Elution profiles of IgG on affinity columns
with immobilized PAB variants. Affinity columns were prepared using the
PAB variants. The captured IgG on the column was eluted with a
decreasing pH gradient. The ordinate on the right indicates the pH of the
solution. The ordinate on the left indicates the absorbance at 280 nm
(mAU: milliabsorbance units). The abscissa indicates the elution volume.
The solid and dashed lines show the elution patterns of IgG on affinity
columns with immobilized PAB variants as shown in the Figure and the
pH value of the elution buffer, respectively.
Additional file 6: Table S3. PAB variants data by mutational
experiments [7, 11, 21-24] and by molecular simulation calculations
[25-26]. The binding affinity of IgG for PAB variants was determined using
ELISA and SPR. None: Almost the same binding affinity, Very small: 2-fold
to < 5-fold decrease, Small: 5-fold to < 10-fold decrease, Large: 10-fold to
< 100-fold decrease, Very large: 100-fold decrease <.
Additional file 7: Figure S5. Circular dichroism melting curves of PAB
variants. (a) The curves of the single histidine substituted PAB variants.
(b) The curves of the double histidine substituted PAB variants. Circular
dichroism melting curves were obtained by monitoring the ellipticity at
222 nm with increasing temperature on a J-805 spectropolarimeter
(JASCO). The mole fractions of the proteins in an unfolded state (thick
lines) are shown as a function of temperature. Theoretical curves (thin
lines) were calculated using a two-state equilibrium transition model.
Additional file 8: Figure S6. Binding efficiency of PAB variants. The
PAB variant (about 72 μg) was immobilized on NHS-activated agarose
gel. The IgG (about 1mg) solution was added to the PAB variant
immobilized agarose gel, and the mixture was shaken at 25°C for 30 min
in pH 9.0 buffer (25 mM Tris–HCl (pH=9.0), 2.5 M NaCl, and 0.1% Tween
20). The amounts of IgG in supernatant after centrifugation were
determined and the binding efficiency was calculated. The ordinate
indicates the binding efficiency.
Additional file 9: Table S4. Amino acid residues of therapeutic
antibodies related to the effects of D36H. In this study, Arg2519 of
IgG-Fab was found to be related to the effects of D36H mutation. Of top
10 therapeutic antibodies in 2010, 80% of the amino acid residues
corresponding to Arg2519 are positively charged residues. Sales rank of
therapeutic antibodies in 2010 are cited from the article (John G. Elvin
et al. International Journal of Pharmaceutics 440 (2013) 83– 98).
Additional file 10: Figure S7. Elution profile of IgG on affinity columns
with immobilized 4×PAZ variants. (a) Elution profile of IgG from affinity
columns prepared with immobilized 4×PAZ01 or 4×PAZ03. IgG was
bound with pH 7.5 buffer (25 mM Tris–HCl (pH=7.5), 150 mM NaCl, and
0.1% Tween 20) at a flow rate of 0.5 mL/min, (b) Elution profile of IgG
from affinity columns prepared with immobilized 4×PAZ01 or 4×PAZ03.
IgG was bound with pH 7.5 buffer (25 mM Tris–HCl (pH=7.5), 150 mM
NaCl, and 0.1% Tween 20) at a flow rate of 0.1 mL/min, (c) Elution profile
of IgG from affinity columns prepared with immobilized 4×PAZ01 or
4×PAZ03. IgG was bound with pH 9.0 buffer (25 mM Tris–HCl (pH=9.0),
2.5 M NaCl, and 0.1% Tween 20) at a flow rate of 0.1 mL/min. Affinity
columns were prepared using the 4×PAZ variants. The captured IgG on
the column was eluted using a buffer with the pH indicated in the
Figure. Afterwards, the residual IgG was eluted with a decreasing pH
gradient. The ordinate on the right indicates the pH of the solution. The
ordinate on the left indicates the absorbance at 280 nm (mAU:
milliabsorbance units). The abscissa indicates the elution volume. The
solid and dashed lines show the elution patterns of IgG on 4×PAZ variant
columns, as shown in the Figure, and the pH value of the elution buffer,
respectively. The inlets show the elution patterns with magnified scale
from 0 to 8 mL.
Additional file 11: Table S1. List of primers. Primers 1~4 indicate the
oligonucleotides for constructing a histidine-scanning library. Primers
5~12 indicate the oligonucleotides for introducing histidine-mutations.
The following abbreviations are used for mixed bases: R=(A or G),
Y=(C or T), M=(A or C), K=(G or T), S=(G or C) and W=(A or T).Abbreviations
SpA: Staphylococcal protein A; Ig: Immunoglobulin; PAB: Staphylococcal
protein A B-domain; PAZ: Staphylococcal protein A Z-domain.
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